Beacon Bispecific Database Summary
- Unrivalled comprehensive & accurate preclinical and clinical Bispecific therapeutic drug, trial and commercial data.
- Access to 3,400+ Drugs, 2,700+ Trials, 2,000+ Companies, and 2,000+ Deals in the Bispecific space
- Market leading ontologies, enabling precise navigation of specific Bispecifics
- Manually curated by Bispecific scientists, with data updated daily
- Your one-stop shop for Bispecific intelligence data
Why Beacon Bispecific Database?
Advanced Filtering
Drill down into Beacon’s Bispecific drug and trial data with a unique selection of >30 search filters. Segment the Bispecific drug and trial landscape to identify the data that matters most to you. Our filters include:
Drug Target
Drug Modality
Disease Indication
Bispecific Mechanism
Molecular Format
Scaffold/Structural Format
Linker
Targeting Moiety
Drug Status
Drug & Trial Milestones
Trial Phase & Location
How Beacon Bispecific Database Can Help You?
Give your Bispecific molecular design the best chance of success for a given target, by gaining a comprehensive overview into successful & failed strategies for a certain scaffold, molecular format, linker, bispecific mechanism and more niche technologies using proprietary Bispecific search ontologies to strategically position your bispecific within niche areas of competition.
Benchmark your preclinical Bispecific research with confidence by accessing more preclinical data than anywhere else, spread across curated in vitro, efficacy, toxicity & PK data alongside half-life & binding affinity released for every bispecific program in one place, allowing you to compare every readout against the wider field
Track clinical bispecifics developments through to approvals with a market leading curation approach to clinical data, searching global trials using 20+ filters including combination searches & segmenting clinical readouts into drug dosing, patient data, toxicity & results from 1000s of public sources. Utilize Beacon to access comprehensive clinical data, benchmark against industry trends, and enhance regulatory and commercial success.
Drastically reduce manual research time with our database solution which allows you to rapidly assemble data for analysis on targets, linkers, molecular formats, bispecific mechanisms, targeting moieties & bispecific modalities in one click
Optimize your bispecific partnership strategy by identifying new prospect companies or competitors as soon as they enter the field, taking advantage of Beacon’s unique approach to capturing early-stage companies and curated insights on deals & pipelines all in one place.
Bulletproof your bispecific investment strategy by confidently communicating your position in the bispecific market to investors, with well benchmarked science, allowing you to stand out in a competitive market using robust data from Beacon.
Beacon helps developers stand out by providing comprehensive insights into targets, diseases, and bispecific design & enhances your ability to attract investors and secure the capital needed to take your bispecific to the next phase.
Beacon Bispecific Database: The Numbers
Beacon Bispecific Database: Key Data Segments
Drug Data
Revolutionize your landscape searching for Bispecifics.
Utilize >20 search filters to find programs based on disease indication, drug modality, bispecific mechanism, scaffold/structural format, linker and many more.
Trial Data
Optimize your Bispecific clinical trial design searching capabilities.
Seamlessly benchmark clinical trial results and search the Bispecific trial landscape based on drug technologies, combination trials, trial locations, trial phase, disease indication and more.
Milestones
A unique Bispecific development milestone filter and visualization tool.
Track past, present, and future Bispecific drug development milestones, including drug and trial readouts, asset history, and regulatory announcements.
Company Data
Your centralized location for Bispecific company intelligence
Identify competitors and business development opportunities, using unique company filters including, company type, HQ locations, operating status & latest funding round, and technologies / diseases targeted in their pipeline.
Deal Data
De-risk your Bispecific partnership & fundraising projects
Search Bispecific deals using custom search filters based on drug technologies involved, deal value & upfront payments, deal types to filter M&As, financing & partnership / licensing deals, geographic market, funding type, and many more.
Beacon Bispecific Database: Drug Modalities
Analyze 3,400+ drugs (preclinical and clinical) and 2,700+ clinical trials (from early to late stage).
Beacon Bispecific covers protein-based biologics that can bind to two or more epitopes (of a protein-based antigen) Drug Modalities include:
- Whole Antibodies
- Antibody Fragments
- Augmented Antibodies
- Bispecific Fusion proteins
- Non-Antibody Scaffolds
- Bispecific Loaded T Cells
Beacon Bispecific also includes a host of preclinical data including, cell line and animal model experimental data.
Who is Beacon Bispecific Database For?
Beacon Bispecific is a manually curated database of comprehensive, high quality, and accurate, preclinical drug, trial and commercial data, offering unrivalled insight into the Bispecific drug development landscape.
Scientific Strategy Leader
Select the right pipeline for your Bispecific drug development
Research Scientist
Validate new targets & inform your Bispecific design
Clinical Development
Design optimized Bispecific clinical trials & benchmark against the competition
Business Development
Uncover new Bispecific licensing, partnership and fundraising opportunities
Competitive Intelligence
Track competitive threats & emerging Bispecific technologies
Translational Development
Confidently take your preclinical Bispecific into the clinic
Related Solutions
Check out additional solutions available from Beacon
Additional Resources
Check out Bispecific related resources available from Beacon
Our Experts
Longli Zhou
Senior Lead Research Analyst
Jake Morris
Commercial Manager
Eleni Taoula
Senior Account Manager
Harvey Dennis
